This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Investigators from the University of Copenhagen, Denmark, and the University of Aberdeen, UK, conducted a population-based prospective cohort study to assess the association between contemporary hormonal contraception (HC) use and breast cancer in women. For the study, the investigators used data from the Danish Hormone Registry Study, which includes information from multiple linked databases. Study participants were women, 15 to 49 years old, living in Denmark on January 1, 1995, and those who turned 15 years old through 2011. The specific type (oral, patch, vaginal ring, implant, injection, or intrauterine system) of HC, and doses of estrogen and progestins, were recorded for study participants. For all women using HC, the length of use was measured and, for …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Related Articles
Cited By...
- No citing articles found.